32036033|t|Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
32036033|a|Inheritance of apolipoprotein E4 (APOE4) is a major risk factor for development of Alzheimer's disease (AD). This lipoprotein, in contrast to apoE2, has arginine residues at positions 112 and 158 in place of cysteines in the latter isoform. In apoE3, the Cys at residue 158 is replaced by an arginine residue. This differential amino acid composition of the three genotypes of APOE have profound influence on the structure, binding properties, and multiple functions of this lipoprotein. Moreover, AD brain is under a high degree of oxidative stress, including that associated with amyloid beta-peptide (Abeta) oligomers. Lipid peroxidation produces the highly reactive and neurotoxic molecule, 4-hydroxynonenal (HNE) that forms covalent bonds with cysteine residues (Cys) [as well as with Lys and His residues]. Covalently modified Cys significantly alter structure and function of modified proteins. HNE bound to Cys residue(s) on apoE2 and apoE3 lessens the chance of HNE damage other proteins. apoE4, lacking Cys residues, is unable to scavenge HNE, permitting this latter neurotoxic molecule to lead to oxidative modification of neuronal proteins and eventual cell death. We posit that this lack of HNE scavenging activity in apoE4 significantly contributes to the association of APOE4 inheritance and increased risk of developing AD. Apoe knock-out mice provide insights into the role of this lipoprotein in oxidative stress. Targeted replacement mice in which the mouse gene of Apoe is separately replaced by the human APOE2, APOE3, or APOE4 genes, while keeping the mouse promoter assures the correct location and amount of the human protein isoform. Human APOE targeted replacement mice have been used to investigate the notion that oxidative damage to and death of neurons in AD and its earlier stages is related to APOE genotype. This current paper reviews the intersection of human APOE genotype, oxidative stress, and diminished function of this lipoprotein as a major contributing risk factor for development of AD. Discussion of potential therapeutic strategies to mitigate against the elevated risk of developing AD with inheritance of the APOE4 allele also is presented.
32036033	0	16	Apolipoprotein E	Gene	348
32036033	65	84	Alzheimer's disease	Disease	MESH:D000544
32036033	101	118	apolipoprotein E4	Gene	348
32036033	120	125	APOE4	Gene	348
32036033	169	188	Alzheimer's disease	Disease	MESH:D000544
32036033	190	192	AD	Disease	MESH:D000544
32036033	228	233	apoE2	Gene	348
32036033	239	273	arginine residues at positions 112	ProteinMutation	tmVar:p|Allele|R|112;VariantGroup:1;CorrespondingGene:348;CorrespondingSpecies:9606
32036033	330	335	apoE3	Gene	348
32036033	341	386	Cys at residue 158 is replaced by an arginine	ProteinMutation	tmVar:p|SUB|C|158|R;HGVS:p.C158R;VariantGroup:0;CorrespondingGene:348;RS#:11542041;CorrespondingSpecies:9606;CA#:9506055
32036033	463	467	APOE	Gene	348
32036033	584	586	AD	Disease	MESH:D000544
32036033	690	695	Abeta	Gene	351
32036033	708	713	Lipid	Chemical	MESH:D008055
32036033	760	770	neurotoxic	Disease	MESH:D020258
32036033	781	797	4-hydroxynonenal	Chemical	MESH:C027576
32036033	799	802	HNE	Chemical	MESH:C027576
32036033	835	843	cysteine	Chemical	MESH:D003545
32036033	876	879	Lys	Chemical	MESH:D008239
32036033	884	887	His	Chemical	MESH:D006639
32036033	988	991	HNE	Chemical	MESH:C027576
32036033	1019	1024	apoE2	Gene	348
32036033	1029	1034	apoE3	Gene	348
32036033	1057	1060	HNE	Chemical	MESH:C027576
32036033	1084	1089	apoE4	Gene	348
32036033	1135	1138	HNE	Chemical	MESH:C027576
32036033	1163	1173	neurotoxic	Disease	MESH:D020258
32036033	1290	1293	HNE	Chemical	MESH:C027576
32036033	1317	1322	apoE4	Gene	348
32036033	1371	1376	APOE4	Gene	348
32036033	1422	1424	AD	Disease	MESH:D000544
32036033	1426	1430	Apoe	Gene	348
32036033	1441	1445	mice	Species	10090
32036033	1539	1543	mice	Species	10090
32036033	1557	1562	mouse	Species	10090
32036033	1571	1575	Apoe	Gene	348
32036033	1606	1611	human	Species	9606
32036033	1612	1617	APOE2	Gene	348
32036033	1619	1624	APOE3	Gene	348
32036033	1629	1634	APOE4	Gene	348
32036033	1660	1665	mouse	Species	10090
32036033	1722	1727	human	Species	9606
32036033	1745	1750	Human	Species	9606
32036033	1751	1755	APOE	Gene	348
32036033	1777	1781	mice	Species	10090
32036033	1872	1874	AD	Disease	MESH:D000544
32036033	1912	1916	APOE	Gene	348
32036033	1974	1979	human	Species	9606
32036033	1980	1984	APOE	Gene	348
32036033	2112	2114	AD	Disease	MESH:D000544
32036033	2215	2217	AD	Disease	MESH:D000544
32036033	2242	2247	APOE4	Gene	348
32036033	Association	MESH:C027576	MESH:D003545
32036033	Association	MESH:C027576	MESH:D008239
32036033	Positive_Correlation	MESH:C027576	MESH:D020258
32036033	Association	MESH:C027576	MESH:D006639
32036033	Association	MESH:C027576	MESH:D008055
32036033	Positive_Correlation	MESH:D000544	348
32036033	Association	MESH:D000544	351
32036033	Association	MESH:C027576	348

